Labeler
Hikma Pharmaceuticals USA Inc. NDC Codes
Hikma Pharmaceuticals USA Inc. lists 754 finished drug products in the FDA NDC Directory under NDC labeler codes 0054, 0143, 0641, 24201.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Tapentadol, Ropivacaine Hydrochloride, Tyzavan, Daptomycin, Lithium Carbonate, Eltrombopag, Cefepime Hydrochloride, Starjemza, Gemcitabine, Vancomycin Hydrochloride, Levetiracetam in Sodium Chloride, dicyclomine hydrochloride, Meropenem, Atropine Sulfate, Fentanyl Citrate
- Active ingredients
- Tapentadol hydrochloride, Ropivacaine hydrochloride, Vancomycin, Daptomycin, Lithium carbonate, Eltrombopag olamine, Cefepime hydrochloride, Ustekinumab, Gemcitabine hydrochloride, Vancomycin hydrochloride, Levetiracetam, Dicyclomine hydrochloride
- NDC labeler codes
- 0054, 0143, 0641, 24201
- Strengths (from the 100 most recently listed products)
- Daptomycin 500 mg/10mL; Ropivacaine hydrochloride 2 mg/mL; Gemcitabine hydrochloride 38 mg/mL; Lithium carbonate 300 mg/1; Daptomycin 350 mg/7mL; Tapentadol hydrochloride 100 mg/1; Tapentadol hydrochloride 50 mg/1; Ropivacaine hydrochloride 5 mg/mL; Cefepime hydrochloride 1 g/1; Cefepime hydrochloride 2 g/1; Ustekinumab 45 mg/.5mL; Fentanyl citrate 50 ug/mL; Glycopyrrolate .2 mg/mL; Mercaptopurine 20 mg/mL; Dicyclomine hydrochloride 10 mg/1; Dicyclomine hydrochloride 20 mg/1; Meropenem 500 mg/10mL; Lithium carbonate 600 mg/1; Lithium carbonate 150 mg/1; Sugammadex sodium 100 mg/mL
- Dosage forms
- Injection, Injection, Solution, Injection, Powder, For solution, Tablet, Injection, Powder, Lyophilized, For solution, Tablet, Film coated, Tablet, Film coated, Extended release, Capsule, Capsule, Gelatin coated, Solution, Suspension, Liquid, Injection, Suspension, Suppository
- Routes
- Intravenous, Oral, Intramuscular, Subcutaneous, Epidural, Infiltration, Perineural, Intravascular, Intrathecal, Ophthalmic, Intra-articular, Rectal
- Drug classes (FDA established)
- Opioid Agonist, Glycopeptide Antibacterial, Amide Local Anesthetic, Anticholinergic, Lipopeptide Antibacterial, Nucleoside Metabolic Inhibitor, Mood Stabilizer, Thrombopoietin Receptor Agonist, Cholinergic Muscarinic Antagonist, Cephalosporin Antibacterial, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Penem Antibacterial, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Polymyxin-class Antibacterial, RANK Ligand Inhibitor, Serotonin-4 Receptor Agonist, Antiarrhythmic, Progesterone, Nondepolarizing Neuromuscular Blocker, Nonsteroidal Anti-inflammatory Drug, Benzodiazepine, Catecholamine, Janus Kinase Inhibitor, Antidote, Antidote for Acetaminophen Overdose, Mucolytic, Central alpha-2 Adrenergic Agonist, Prostaglandin Analog, Phenylalanine Hydroxylase Activator, Atypical Antipsychotic, beta-Adrenergic Blocker, Opioid Antagonist, Oxidation-Reduction Agent, Corticosteroid, GLP-1 Receptor Agonist, Norepinephrine Releasing Agent
- HCPCS / J-code
- J0171 — Injection, adrenalin, epinephrine, 0.1 mg, J0897 — Injection, denosumab, 1 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg
- Package NDCs
- 111 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | 0143-9430 | 00143-9430-10 | — |
| Meropenem | Meropenem 1 g/30mL | InjectionIntravenous | 0143-9431 | 00143-9431-10 | — |
| pyrazinamide | Pyrazinamide 500 mg/1 | TabletOral | 0054-0812 | 00054-0812-2100054-0812-2200054-0812-25+1 more | — |
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | 0143-9156 | 00143-9156-10 | — |
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | 0143-9157 | 00143-9157-10 | — |
| calcium gluconate | Calcium gluconate monohydrate 98 mg/mL | Injection, SolutionIntravenous | 0143-9185 | 00143-9185-20 | — |
| Eribulin Mesylate | Eribulin mesylate .5 mg/mL | InjectionIntravenous | 0143-9167 | 00143-9167-01 | — |
| Clindamycin in 5 percent Dextrose | Clindamycin 18 mg/mL | Injection, SolutionIntravenous | 0143-9269 | 00143-9269-01 | — |
| Clindamycin in 5 percent Dextroseclindamycin in percent dextrose | Clindamycin 6 mg/mL | Injection, SolutionIntravenous | 0143-9267 | 00143-9267-01 | — |
| Clindamycin in 5 percent Dextrose | Clindamycin 12 mg/mL | Injection, SolutionIntravenous | 0143-9268 | 00143-9268-01 | — |
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | 0143-9155 | 00143-9155-25 | — |
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | 0143-9158 | 00143-9158-01 | — |
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | 0143-9159 | 00143-9159-01 | — |
| Sodium Acetate | Sodium acetate anhydrous 164 mg/mL | InjectionIntravenous | 0641-6261 | 00641-6261-01 | — |
| Sodium Acetate | Sodium acetate anhydrous 164 mg/mL | InjectionIntravenous | 0641-6262 | 00641-6262-01 | — |
| Sodium Acetate | Sodium acetate anhydrous 164 mg/mL | InjectionIntravenous | 0641-6263 | 00641-6263-10 | — |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride .5 mg/.5mL | InjectionIntramuscular, Intravenous, Subcutaneous | 0641-6206 | 00641-6206-10 | — |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 1 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 0641-6169 | 00641-6169-10 | — |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 2 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 0641-6170 | 00641-6170-10 | — |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride .2 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 0641-6259 | 00641-6259-10 | — |
| Midazolam | Midazolam hydrochloride 5 mg/mL | InjectionIntramuscular, Intravenous | 0641-6218 | 00641-6218-10 | — |
| Midazolam | Midazolam hydrochloride 5 mg/mL | InjectionIntramuscular, Intravenous | 0641-6219 | 00641-6219-10 | — |
| Midazolam | Midazolam hydrochloride 1 mg/mL | InjectionIntramuscular, Intravenous | 0641-6220 | 00641-6220-10 | — |
| Alvimopan | Alvimopan 12 mg/1 | CapsuleOral | 0054-0668 | 00054-0668-82 | — |
| Combogesic IVacetaminophen and ibuprofen injection | Acetaminophen 1000 mg/100mL; Ibuprofen 300 mg/100mL | InjectionIntravenous | 0143-9150 | 00143-9150-10 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 10 mg/1 | CapsuleOral | 0054-0660 | 00054-0660-25 | — |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9182 | 00143-9182-01 | — |
| Caffeine Citrate | Caffeine citrate 20 mg/mL | InjectionIntravenous | 0641-6267 | 00641-6267-10 | — |
| Foscarnet Sodium | Foscarnet sodium 24 mg/mL | Injection, SolutionIntravenous | 0143-9192 | 00143-9192-01 | — |
| calcium gluconate | Calcium gluconate monohydrate 98 mg/mL | Injection, SolutionIntravenous | 0143-9184 | 00143-9184-25 | — |
| calcium gluconate | Calcium gluconate monohydrate 98 mg/mL | Injection, SolutionIntravenous | 0143-9180 | 00143-9180-25 | — |
| Thiotepa | Thiotepa 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntracavitary, Intravenous, Intravesical | 0143-9292 | 00143-9292-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 60 mg/1 | CapsuleOral | 0054-0374 | 00054-0374-25 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 40 mg/1 | CapsuleOral | 0054-0372 | 00054-0372-25 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 20 mg/1 | CapsuleOral | 0054-0370 | 00054-0370-25 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 70 mg/1 | CapsuleOral | 0054-0375 | 00054-0375-25 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 50 mg/1 | CapsuleOral | 0054-0373 | 00054-0373-25 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 30 mg/1 | CapsuleOral | 0054-0371 | 00054-0371-25 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 1.25 g/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9152 | 00143-9152-10 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 1.5 g/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9153 | 00143-9153-10 | — |
| Levocarnitine | Levocarnitine 1 g/5mL | InjectionIntravenous | 0143-9852 | 00143-9852-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | 0143-9396 | 00143-9396-01 | — |
| Midazolam in Sodium Chloride | Midazolam hydrochloride 1 mg/mL | InjectionIntravenous | 0143-9379 | 00143-9379-10 | — |
| Midazolam in Sodium Chloride | Midazolam hydrochloride 1 mg/mL | InjectionIntravenous | 0143-9380 | 00143-9380-10 | — |
| Sterile Water | Water 1 mL/mL | Injection, SolutionIntravenous | 0143-9339 | 00143-9339-12 | — |
| Dobutamine | Dobutamine hydrochloride 12.5 mg/mL | Injection, SolutionIntravenous | 0143-9141 | 00143-9141-10 | — |
| Medroxyprogesterone Acetate Injectable Suspensionmedroxyprogesterone acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | 24201-150 | 24201-0150-0124201-0150-25 | J1050 |
| Regadenoson | Regadenoson anhydrous .08 mg/mL | Injection, SolutionIntravenous | 0641-6253 | 00641-6253-01 | — |
| Dihydroergotamine Mesylate | Dihydroergotamine mesylate 1 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 0143-9151 | 00143-9151-10 | — |
| posaconazole | Posaconazole 40 mg/mL | SuspensionOral | 0054-0449 | 00054-0449-49 | — |
Hikma Pharmaceuticals USA Inc.: common questions
- What is Hikma Pharmaceuticals USA Inc.'s NDC labeler code?
- 0054, 0143, 0641, 24201. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Hikma Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J0171, J0897, J3357 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.